Table 3.
Mortality rates for DA-HAIs
| Mortality | Relative Risk | ||||||
|---|---|---|---|---|---|---|---|
| Total patients | Crude | Crude excess | 95 CI | ||||
| N | RR | Lower | Upper | ||||
| Nonea | 151 | 25 | 16.6 | ||||
| VAP | 13 | 5 | 38.5 | 21.8 | 2.33 | 1.07 | 5.05 |
| CLABSI | 15 | 5 | 33.3 | 16.7 | 2.01 | 0.90 | 4.48 |
| CAUTI | 6 | 2 | 33.3 | 16.7 | 2.01 | 0.61 | 6.58 |
aPatients admitted with no HAI and acquired no HAI no DA-HAI. Table presents Risk Ratios (RRs) unadjusted of any demographic characteristics. The multivariate model adjusting for Age revieled the following RRs: VAP:RR = 3.62 95% C.I.(1.64–7.98), CLABSI:RR = 2.32 95% C.I.(1.04–5.15), CAUTI:RR = 2.37 95% C.I.(0.73–7.74)